Results 211 to 220 of about 144,610 (311)
MRI-Based Radiomics to Predict Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Retrospective Study. [PDF]
Ambrosini I +9 more
europepmc +1 more source
ABSTRACT Background Steatotic liver disease (SLD) is an unrecognized complication after pancreaticoduodenectomy (PD) and may affect nutrition and long‐term recovery. This meta‐analysis estimated the incidence of SLD after PD and identified its clinical and surgical risk factors.
Ronnakorn Kongsakon +4 more
wiley +1 more source
Organ Preservation After Total Neoadjuvant Therapy in a Patient With Low Rectal Adenocarcinoma and Crohn's Disease. [PDF]
Leong R +4 more
europepmc +1 more source
ABSTRACT Background/Purpose Prognostic significance of preoperative patient‐related factors, including oral health status, in pancreatic ductal adenocarcinoma (PDAC) remains unclear. We evaluated the association between preoperative factors—particularly oral health parameters—and long‐term survival after curative PDAC resection.
Kaoru Seo +8 more
wiley +1 more source
Surgical Perspectives on Neoadjuvant Therapy in Borderline Resectable and Locally Advanced Pancreatic Cancer. [PDF]
Zhang J +4 more
europepmc +1 more source
Postoperative Weight Gain, Due to Fluid Retention After Ovarian Cancer Surgery—How Much Is too Much?
ABSTRACT Background and Objectives Postoperative complications after cytoreductive surgery in ovarian cancer patients are associated with impaired survival. Here, we investigated the association between postoperative weight gain due to fluid retention and the development of complications and anastomotic leakage (AL).
Eva K. Egger +7 more
wiley +1 more source
Outcomes of robotic anatomic lung resection after neoadjuvant therapy for non-small cell lung cancer. [PDF]
Yongue C +7 more
europepmc +1 more source
ABSTRACT Background The peritoneum is the third most prevalent location for metastases of colorectal cancer. In patients with resectable disease, cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS‐HIPEC) is the preferred treatment in the Netherlands, achieving median overall survival (OS) of 36–42 months. However, during
Teun van den Heuvel +6 more
wiley +1 more source
Axillary surgery after neoadjuvant therapy: rethinking completion axillary dissection for residual micrometastatic disease. [PDF]
Rizk M, Mokbel K, Mokbel K.
europepmc +1 more source

